Meanwhile back in Corporate Synbioville...
Submitted by Jim Thomas on
The BP-Berkeley deal, the new joint Bio Energy institute, and also the recent job hop by John Menlo of BP fuels to Amyris Biotech - are all extra strings tying the interests of the Syn Bio community as a wholeever closer to the interests of big business. It should be noted that in each of thse cases CEO Keasling plays a central role. The same man who claims to be developing Synthetic Biology to serve the worlds poor (via synthetic artemisinin) seems to be rather busy these days serving the fabulously rich.